-
Loading metrics
Open Access
Peer-reviewed
Research Article
Selective killing of homologous recombination-deficient cancer cell lines by inhibitors of the RPA:RAD52 protein-protein interaction
-
Mona Al-Mugotir,
Roles Investigation, Writing – original draft
Affiliation The Eppley Institute for Research in Cancer and Allied Diseases, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska, United States of America
⨯ -
Jeffrey J. Lovelace,
Roles Writing – review & editing
Affiliation The Eppley Institute for Research in Cancer and Allied Diseases, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska, United States of America
⨯ -
Joseph George,
Roles Investigation
Affiliation The Eppley Institute for Research in Cancer and Allied Diseases, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska, United States of America
⨯ -
Mika Bessho,
Roles Investigation
Affiliation The Eppley Institute for Research in Cancer and Allied Diseases, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska, United States of America
⨯ -
Dhananjaya Pal,
Roles Investigation
Affiliation The Eppley Institute for Research in Cancer and Allied Diseases, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska, United States of America
⨯ -
Lucas Struble,
Roles Investigation
Affiliation The Eppley Institute for Research in Cancer and Allied Diseases, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska, United States of America
⨯ -
Carol Kolar,
Roles Investigation
Affiliation The Eppley Institute for Research in Cancer and Allied Diseases, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska, United States of America
⨯ -
Sandeep Rana,
Roles Investigation, Validation
Affiliation The Eppley Institute for Research in Cancer and Allied Diseases, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska, United States of America
⨯ -
Amarnath Natarajan,
Roles Conceptualization
Affiliation The Eppley Institute for Research in Cancer and Allied Diseases, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska, United States of America
⨯ -
Tadayoshi Bessho ,
Roles Conceptualization, Funding acquisition, Investigation, Methodology, Visualization, Writing – review & editing
* E-mail: gborgstahl@unmc.edu (GEOB); tbessho@unmc.edu (TB)
Affiliation The Eppley Institute for Research in Cancer and Allied Diseases, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska, United States of America
⨯ -
Gloria E. O. Borgstahl
Roles Conceptualization, Funding acquisition, Supervision, Writing – original draft, Writing – review & editing
* E-mail: gborgstahl@unmc.edu (GEOB); tbessho@unmc.edu (TB)
Affiliation The Eppley Institute for Research in Cancer and Allied Diseases, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska, United States of America
⨯
Selective killing of homologous recombination-deficient cancer cell lines by inhibitors of the RPA:RAD52 protein-protein interaction
- Mona Al-Mugotir,
- Jeffrey J. Lovelace,
- Joseph George,
- Mika Bessho,
- Dhananjaya Pal,
- Lucas Struble,
- Carol Kolar,
- Sandeep Rana,
- Amarnath Natarajan,
- Tadayoshi Bessho
- Published: March 30, 2021
- https://doi.org/10.1371/journal.pone.0248941